Bienvenue chez nous !
Logo Ex Libris
 Laissez-vous inspirer ! 

Therapeutic Lipidology

  • Livre Relié
  • 512 Nombre de pages
(0) Donner la première évaluation
Afficher toutes les évaluations
Since the creation of the American Board of Clinical Lipidology, many clinicians have wanted an up-to-date, comprehensive referenc... Lire la suite
CHF 370.00
Impression sur demande - Habituellement expédié sous 4 à 6 semaines.
Commande avec livraison dans une succursale


Since the creation of the American Board of Clinical Lipidology, many clinicians have wanted an up-to-date, comprehensive reference on lipidology. Now, for the first time, clinicians can find such a reference in Therapeutic Lipidology. This volume will provide practicing clinicians with a focused and intensive but useable source of information on the identification and management of dyslipidemias. Among the topics discussed in this groundbreaking text are lipoprotein metabolism, pharmacological therapy for cardiovascular disease, thiazolidinediones on serum lipoproteins, hypertriglyceridemia, dyslipidemia and obesity, dyslipidemia in children, and much more.

The pace of scientific and clinical advances in lipidology is astounding. This reference will serve as a lifelong stimulus to the reader to continue to learn about the ever changing and fascinating field of therapeutic lipidology. Comprehensive and cutting-edge, Therapeutic Lipidology will empower readers to improve and extend the lives of the patients they so conscientiously serve.

An up-to-date, comprehensive reference on lipidology

Provides a focused and intensive source for the identification and management of dyslipidemias

Covers dyslipidemia management in obesity, cardiovascular disease, women, and children

Therapeutic Lipidology Table of Contents Chapter 1 Lipoprotein Metabolism and Vascular Biology Brian G. Choi, M.D., M.B.A. Juan J. Badimon, Ph.D. Pedro R. Moreno, M.D. Valentin Fuster, M.D., Ph.D. Lipoprotein Classification Apolipoprotein Classification Lipid Metabolism HDL Metabolism Lipoprotein Metabolism Regulation Lipids in Vascular Biology and Atherothrombosis Chapter 2 Genetic Disorders of Lipoprotein Metabolism Marina Cuchel, M.D., Ph.D. Atif Qasim, M.D. Daniel J. Rader, M.D. Lipid Disorders Involving Elevated Triglycerides Inherited Syndromes of Elevated LDL-Cholesterol Inherited Syndromes of Low LDL-Cholesterol Inherited Syndromes of Low HDL-C Inherited Syndromes of Elevated HDL-C Levels Chapter 3 International Guidelines for Dyslipidemia Management Cathleen E. Maki, R.N., M.S.N., N.P. The Canadian Guidelines The European Guidelines Joint British Societies Guidelines Chapter 4 Pathophysiology and Management of Dyslipidemias Associated with Obesity, Type 2 Diabetes and Other Insulin Resistant States Kevin C. Maki, Ph.D. Obesity and Type 2 Diabetes Mellitus Cardiometabolic Risk Syndrome Lipid Abnormalities Associated with Insulin Resistance Functions of Insulin Excessive Production of Very-low Density Lipoproteins (VLDL): The Primary Lipid Abnormality in the Insulin Resistant State Reasons for Elevated Free Fatty Acid Levels in Insulin Resistant States Formation of Small, Dense LDL Particles Mechanisms Linking Insulin Resistance to Low HDL Cholesterol Activities of Lipoprotein and Hepatic Lipases and Their Relationships to Atherogenic Dyslipidemia Lifestyle Management for Atherogenic Dyslipidemia Drug Therapies for Atherogenic Dyslipidemia Intensification of Efforts to Lower LDL-C as a Means of Achieving the Non-HDL-C Goal Targeting Triglyceride-rich Lipoprotein Reduction as a Means of AchievingNon-HDL-C Goal Management of Diabetic Dyslipidemia Chapter 5 C-Reactive Protein and Other Inflammatory Markers in Cardiovascular Disease Natalie Khuseyinova, M.D. Wolfgang Koenig, M.D., Ph.D. C-reactive Protein Cytokines Markers of Hemostasis, that are also Acute Phase Reactants Plasminogen Activator Inhibitor-1 D-Dimer Von Willebrand Factor White Blood Cell Count Lipid-related Biomarkers Oxidised (Ox) LDL Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Adiponectin Chapter 6 Dietary Prescriptions to Control Dyslipidemias and Coronary Disease Risk Margo A. Denke, M.D. A Diet-Enthusiast's Summary of The Evolving Role of Diet Pre-Statin Cholesterol Lowering (1960-1987) Early Statin Years: LDL Lowering (1987-1994) Landmark Statin Trials, LDL Lowering and Eruption of the Metabolic Syndrome (1994-2004) Lipid Therapy Beyond LDL and CHD Prevention Dietary Therapies Beyond Lipids 2004-present Chapter 7 Pharmacological Therapy for Cardiovascular Disease: Current and Emerging Therapies Michael H. Davidson, M.D., F.A.C.C., F.A.C.P. Statins Ezetimibe Bile Acid Sequestrants Niacin Fibrates Omega-3 Fatty Acids Chapter 8 Effects of Thiazolidinediones on Serum Lipoproteins Anjli Maroo, M.D., R.V.T. W. H. Wilson Tang, M.D., F.A.C.C. Mechanisms of TZD Actions on Serum Lipoproteins Clinical Evidence of Lipid Lowering Effects of TZDs Meta-Analyses of Pioglitazone and Rosiglitazone Trials Prospective Comparative Clinical Studies Concomitant TZD and Statin Therapy Outcome Studies Future Directions Chapter 9 High-Density Lipoproteins Peter P. Toth, M.D., Ph.D. Antiatherogenic Effects of HDL Epidemiologic Studies Evaluating the Relationship between HDL and Risk for Cardiovascular Disease The Definition and Prevalence of Low HDL Effects of Lifestyle Modification on HDL Pharmacologic Therapy for Low

Informations sur le produit

Titre: Therapeutic Lipidology
Code EAN: 9781588295514
ISBN: 1588295516
Format: Livre Relié
Editeur: Humana Press
Genre: Médecine
nombre de pages: 512
Poids: 1150g
Taille: H260mm x B183mm x T32mm
Année: 2007
Auflage: 2007

Autres articles de cette série  "Contemporary Cardiology"